BIOCON NSE filing

Biocon Limited Reminds Shareholders to Update KYC Details for Physical Holdings

The RealCase readLow impact Neutral

Biocon Limited is reminding shareholders with physical shareholdings to update their KYC details as per SEBI mandate. Non-compliance by February 06, 2026, may lead to withholding of payments like dividends. Shareholders must submit forms ISR-1 and ISR-2 with supporting documents to the RTA.

Why it matters

This is a routine compliance communication to shareholders holding shares in physical form and does not involve any new business development, financial results, or strategic changes that would significantly impact the company.

The market read

The announcement is a procedural reminder to shareholders regarding KYC compliance and does not contain any new financial or operational information that would positively or negatively impact the company's outlook.

Biocon Limited has issued a reminder to shareholders holding shares in physical form to furnish their Know Your Customer (KYC) details. This action is in compliance with SEBI Master Circular no. HO/38/13/(4)2026-MIRSD-POD/I/4298/2026, dated February 06, 2026.

The SEBI Master Circular mandates that security holders with physical shares must update their KYC details, including PAN, contact information, mobile number, bank account details, and signature. Failure to do so will result in the withholding of payments such as dividends, interest, or redemption amounts.

Shareholders are requested to submit updated KYC details using Form ISR-1 and Form ISR-2, along with supporting documents like a bank passbook or statement and a cancelled cheque with their name printed. These forms and the SEBI Master Circular can be downloaded from Biocon's website or the RTA's website, Kfin Technologies Limited. Submissions can be made via courier of hard copies, through electronic mode with digital signatures, or via the RTA's web portal.

Filing to action

What to do with a filing like this

Biocon Limited filed this with the NSE as a statutory disclosure, categorised under other regulatory filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Biocon Limited. Read the original for the full detail.

View original filing